Skip to main content
Signal8

BRAENDER LORI J

SEC insider (Form 3/4/5 filer). CIK 0001752955. Corporate Secretary at Aquestive Therapeutics, Inc. (AQST). 8 reported Form 4/5 transactions since Sep 2024; latest on May 7, 2026. Located in WARREN, NJ.

Companies BRAENDER LORI J has filed insider reports for

  • Aquestive Therapeutics, Inc. (AQST): Officer, Corporate Secretary
BRAENDER LORI J profile photo

BRAENDER LORI J

CIK: 0001752955

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (12.5%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (37.5%)

Compensation grants

Other (G, F, J, C, D, …)4 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Aquestive Therapeutics, Inc. logo
AQST

Aquestive Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

  • Aquestive Therapeutics, Inc. logo
    AQST

    Aquestive Therapeutics, Inc.

    May 7, 2026
    Tax Payment
    Direct
    135.7K shares at avg. $4.23$574K
  • Aquestive Therapeutics, Inc. logo
    AQST

    Aquestive Therapeutics, Inc.

    May 5, 2026
    Tax Payment
    Direct
    76.1K shares at avg. $4.18$318K
  • Aquestive Therapeutics, Inc. logo
    AQST

    Aquestive Therapeutics, Inc.

    Mar 10, 2026
    Sale
    Direct
    40.1K shares at avg. $4.17$167K
  • Aquestive Therapeutics, Inc. logo
    AQST

    Aquestive Therapeutics, Inc.

    Mar 9, 2026
    Award
    Direct
    80K shares-
  • Aquestive Therapeutics, Inc. logo
    AQST

    Aquestive Therapeutics, Inc.

    Mar 9, 2025
    Tax Payment
    Direct
    10.7K shares at avg. $2.65$28K
  • Aquestive Therapeutics, Inc. logo
    AQST

    Aquestive Therapeutics, Inc.

    Mar 7, 2025
    Award

    Performance Stock Units

    Direct
    82.5K shares-
  • Aquestive Therapeutics, Inc. logo
    AQST

    Aquestive Therapeutics, Inc.

    Mar 7, 2025
    Tax Payment
    Direct
    9.6K shares at avg. $2.65$25K
  • Aquestive Therapeutics, Inc. logo
    AQST

    Aquestive Therapeutics, Inc.

    Mar 7, 2025
    Award
    Direct
    110K shares-

1-8 of 8